Licensing of ASCs with TNF and/or IFNγ was reported to enhance the immunosuppressive functions of these cells, including inhibition of T cell proliferation [60, 61], which is in line with present results concerning HD/ASCs. The gene discussed is TNF; the disease is Huntington disease.